Literature DB >> 26612101

Altered activation of the diaphragm in late-onset Pompe disease.

Barbara K Smith1, Manuela Corti2, A Daniel Martin3, David D Fuller3, Barry J Byrne2.   

Abstract

Pompe disease is an inherited neuromuscular disorder that affects respiratory function and leads to dependence on external ventilatory support. We studied the activation of the diaphragm using bilateral phrenic magnetic stimulation and hypothesized that diaphragm compound muscle action potential (CMAP) amplitude and evoked transdiaphragmatic pressure (Twitch PDI) would correlate to disease severity. Eight patients with late onset Pompe disease (LOPD, aged 14-48 years) and four healthy control subjects completed the tests. Maximal Twitch PDI responses were progressively reduced in patients with LOPD compared to control subjects (1.4-17.1cm H2O, p<0.001) and correlated to voluntary functional tests (p<0.05). Additionally, CMAP amplitude (mA) was lower in the patients who used nighttime or fulltime ventilatory support, when compared to controls and patients who used no ventilatory support (p<0.005). However, the normalized (%peak) Twitch PDI and CMAP responses were similar between patients and controls. This suggests a loss of functional phrenic motor units in patients, with normal recruitment of remaining motor units.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diaphragm; Neuromuscular; Pompe; Stimulation; Ventilator

Mesh:

Year:  2015        PMID: 26612101      PMCID: PMC4869700          DOI: 10.1016/j.resp.2015.11.013

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  11 in total

1.  Validation of improved recording site to measure phrenic conduction from surface electrodes in humans.

Authors:  Eric Verin; Christian Straus; Alexandre Demoule; Philippe Mialon; Jean-Philippe Derenne; Thomas Similowski
Journal:  J Appl Physiol (1985)       Date:  2002-03

2.  Supine volume drop and diaphragmatic function in adults with Pompe disease.

Authors:  Hélène Prigent; David Orlikowski; Pascal Laforêt; Nadège Letilly; Line Falaize; Nadine Pellegrini; Djillali Annane; Jean-Claude Raphael; Frédéric Lofaso
Journal:  Eur Respir J       Date:  2012-06       Impact factor: 16.671

3.  Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease.

Authors:  Cathryn S Mah; Darin J Falk; Sean A Germain; Jeffry S Kelley; Melissa A Lewis; Denise A Cloutier; Lara R DeRuisseau; Thomas J Conlon; Kerry O Cresawn; Thomas J Fraites; Martha Campbell-Thompson; David D Fuller; Barry J Byrne
Journal:  Mol Ther       Date:  2010-01-26       Impact factor: 11.454

4.  Bilateral magnetic stimulation of the phrenic nerves from an anterolateral approach.

Authors:  G H Mills; D Kyroussis; C H Hamnegard; M I Polkey; M Green; J Moxham
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

Review 5.  The respiratory neuromuscular system in Pompe disease.

Authors:  David D Fuller; Mai K ElMallah; Barbara K Smith; Manuela Corti; Lee Ann Lawson; Darin J Falk; Barry J Byrne
Journal:  Respir Physiol Neurobiol       Date:  2013-06-21       Impact factor: 1.931

6.  Electromyographic findings in 37 patients with adult-onset acid maltase deficiency.

Authors:  Charles D Kassardjian; Andrew G Engel; Eric J Sorenson
Journal:  Muscle Nerve       Date:  2015-03-31       Impact factor: 3.217

7.  Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease.

Authors:  N Pellegrini; P Laforet; D Orlikowski; M Pellegrini; C Caillaud; B Eymard; J-C Raphael; F Lofaso
Journal:  Eur Respir J       Date:  2005-12       Impact factor: 16.671

8.  Reproducible measurement of human motoneuron excitability with magnetic stimulation of the corticospinal tract.

Authors:  Peter G Martin; Anna L Hudson; Simon C Gandevia; Janet L Taylor
Journal:  J Neurophysiol       Date:  2009-04-29       Impact factor: 2.714

9.  Respiratory muscle activity during REM sleep in patients with diaphragm paralysis.

Authors:  J R Bennett; H M A Dunroy; D R Corfield; N Hart; A K Simonds; M I Polkey; M J Morrell
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

10.  Neural deficits contribute to respiratory insufficiency in Pompe disease.

Authors:  Lara R DeRuisseau; David D Fuller; Kai Qiu; Keith C DeRuisseau; William H Donnelly; Cathryn Mah; Paul J Reier; Barry J Byrne
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

View more
  11 in total

Review 1.  Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy.

Authors:  Barry J Byrne; David D Fuller; Barbara K Smith; Nathalie Clement; Kirsten Coleman; Brian Cleaver; Lauren Vaught; Darin J Falk; Angela McCall; Manuela Corti
Journal:  Ann Transl Med       Date:  2019-07

2.  Transcriptome assessment of the Pompe (Gaa-/-) mouse spinal cord indicates widespread neuropathology.

Authors:  S M F Turner; D J Falk; B J Byrne; D D Fuller
Journal:  Physiol Genomics       Date:  2016-09-09       Impact factor: 3.107

3.  Cough Effectiveness and Pulmonary Hygiene Practices in Patients with Pompe Disease.

Authors:  Teresa Pitts; Rachel Bordelon; Alyssa Huff; Barry J Byrne; Barbara K Smith
Journal:  Lung       Date:  2018-10-25       Impact factor: 2.584

4.  Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(-/-)) mice.

Authors:  Sara M F Turner; Aaron K Hoyt; Mai K ElMallah; Darin J Falk; Barry J Byrne; David D Fuller
Journal:  Respir Physiol Neurobiol       Date:  2016-02-26       Impact factor: 1.931

5.  Quantitative analysis of upright standing in adults with late-onset Pompe disease.

Authors:  Maria Stella Valle; Antonino Casabona; Agata Fiumara; Dora Castiglione; Giovanni Sorge; Matteo Cioni
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

6.  Comprehensive approach to weaning in difficult-to-wean infantile and juvenile-onset glycogen-storage disease type II patients: a case series.

Authors:  Lingling Xu; Hongjun Ba; Yuxin Pei; Xueqiong Huang; Yujian Liang; Lidan Zhang; Huimin Huang; Cheng Zhang; Wen Tang
Journal:  Ital J Pediatr       Date:  2019-08-22       Impact factor: 2.638

7.  Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects.

Authors:  Pasqualina Colella; Pauline Sellier; Manuel J Gomez; Maria G Biferi; Guillaume Tanniou; Nicolas Guerchet; Mathilde Cohen-Tannoudji; Maryse Moya-Nilges; Laetitia van Wittenberghe; Natalie Daniele; Bernard Gjata; Jacomina Krijnse-Locker; Fanny Collaud; Marcelo Simon-Sola; Severine Charles; Umut Cagin; Federico Mingozzi
Journal:  EBioMedicine       Date:  2020-10-09       Impact factor: 8.143

8.  Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticity.

Authors:  Barbara K Smith; A Daniel Martin; Lee Ann Lawson; Valerie Vernot; Jordan Marcus; Saleem Islam; Nadeem Shafi; Manuela Corti; Shelley W Collins; Barry J Byrne
Journal:  Exp Neurol       Date:  2016-07-21       Impact factor: 5.330

9.  Case Studies in Neuroscience: Neuropathology and diaphragm dysfunction in ventilatory failure from late-onset Pompe disease.

Authors:  David D Fuller; Jorge A Trejo-Lopez; Anthony T Yachnis; Michael D Sunshine; Sabhya Rana; Victoria E Bindi; Barry J Byrne; Barbara K Smith
Journal:  J Neurophysiol       Date:  2021-06-30       Impact factor: 2.974

10.  Dynamic respiratory muscle function in late-onset Pompe disease.

Authors:  Barbara K Smith; Shannon Allen; Samantha Mays; A Daniel Martin; Barry J Byrne
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.